Evidence map›Paper›PMID 34632575›Full record

ArticleBritish journal of haematology2022

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J Chavda, Emma Dowling, Nuno Correia, Catherine S Y Lecat, Annabel McMillan and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Wei Yee ChanDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0003-0471-2059
Lara HowellsDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
William WilsonCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Emilie SanchezDepartment of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
Louise AinleyDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0003-0630-7065
Selina J ChavdaDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-1359-9847
Emma DowlingHCA Healthcare at University College London Hospitals NHS Foundation Trust, London, UK.
Nuno CorreiaHCA Healthcare at University College London Hospitals NHS Foundation Trust, London, UK.
Catherine S Y LecatDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0001-9233-6967
Annabel McMillanDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0003-0624-165X
Brendan WisniowskiDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Shameem MahmoodDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Xenofon PapanikolaouDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Lydia LeeDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Jonathan SiveDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-1393-2793
Charalampia KyriakouDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Ashutosh WechalekarDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Rakesh PopatDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Neil RabinDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Eleni NastouliDepartment of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
Kwee L YongDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-6487-276X
Ke XuDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-2453-4475

Funding

Medical Research Council MR/S001883/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

VaccinationAgedAntibodies, ViralBNT162 VaccineChAdOx1 nCoV-19COVID-19FemaleHumansMaleMonoclonal Gammopathy of Undetermined SignificanceSARS-CoV-2Smoldering Multiple MyelomaAntibodies, ViralBNT162 VaccineChAdOx1 nCoV-19humoral responsemultiple myelomaplasma cell disorderssevere acute respiratory syndrome coronavirus-2vaccination response

Identifiers

PMID34632575
PMCPMC8652995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.